Detalhe da pesquisa
1.
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
N Engl J Med
; 387(1): 9-20, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665782
2.
Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib.
Br J Cancer
; 130(7): 1141-1148, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38280968
3.
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
N Engl J Med
; 385(25): 2336-2347, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914339
4.
Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancer.
Future Oncol
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38592002
5.
Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancer.
Strahlenther Onkol
; 199(1): 30-37, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35648170
6.
Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy.
Eur Radiol
; 33(11): 8142-8154, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318605
7.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 23(11): 1367-1377, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36183733
8.
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
Oncologist
; 27(7): e561-e570, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278078
9.
Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS.
Anal Chem
; 94(16): 6297-6303, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35416669
10.
Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients: results from the randomized study OSS.
Support Care Cancer
; 31(1): 82, 2022 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574052
11.
Improving breast cancer sensitivity to paclitaxel by increasing aneuploidy.
Proc Natl Acad Sci U S A
; 116(47): 23691-23697, 2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31685623
12.
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.
Lancet Oncol
; 22(1): 85-97, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33357420
13.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Lancet Oncol
; 22(4): 476-488, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721561
14.
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients.
Breast Cancer Res
; 23(1): 31, 2021 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676547
15.
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study.
Breast Cancer Res
; 23(1): 9, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468209
16.
Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore.
Br J Cancer
; 124(8): 1421-1427, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33558711
17.
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.
Br J Cancer
; 124(7): 1207-1213, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33473163
18.
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.
Br J Cancer
; 125(11): 1486-1493, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34588616
19.
HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer.
Breast Cancer Res
; 22(1): 86, 2020 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32787900
20.
Plasma thymidine kinase 1 activity and outcome of ER+ HER2- metastatic breast cancer patients treated with palbociclib and endocrine therapy.
Breast Cancer Res
; 22(1): 98, 2020 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32928264